Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1051 | 10071 | 45.0 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
422 | 3 | C REACTIVE PROTEIN//STAT3//HAPTOGLOBIN | 28303 |
1051 | 2 | STAT3//GP130//ONCOSTATIN M | 10071 |
2728 | 1 | INTERLEUKIN 6 RECEPTOR//IL 6 RECEPTOR//GP130 | 2164 |
3696 | 1 | STAT1//STAT5//STAT | 1929 |
4688 | 1 | ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR//CILIARY NEUROTROPHIC FACTOR | 1743 |
5366 | 1 | STAT3//GRIM 19//STAT3 INHIBITOR | 1633 |
7798 | 1 | SOCS1//SOCS//SOCS3 | 1326 |
13676 | 1 | TOFACITINIB//JAK3//JANUS KINASE | 820 |
20517 | 1 | INTERLEUKIN 11//IL 11//RECOMBINANT HUMAN INTERLEUKIN 11 | 456 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | STAT3 | authKW | 662801 | 8% | 27% | 801 |
2 | GP130 | authKW | 352419 | 2% | 52% | 225 |
3 | ONCOSTATIN M | authKW | 311552 | 2% | 58% | 178 |
4 | LEUKEMIA INHIBITORY FACTOR | authKW | 266481 | 2% | 41% | 216 |
5 | CILIARY NEUROTROPHIC FACTOR | authKW | 215322 | 2% | 44% | 162 |
6 | SOCS | authKW | 184932 | 1% | 52% | 118 |
7 | STAT | authKW | 174342 | 2% | 29% | 202 |
8 | SOCS3 | authKW | 173437 | 1% | 41% | 141 |
9 | SOCS1 | authKW | 164462 | 1% | 52% | 105 |
10 | INTERLEUKIN 11 | authKW | 159811 | 1% | 49% | 108 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 15718 | 21% | 0% | 2164 |
2 | Immunology | 14604 | 20% | 0% | 1966 |
3 | Biochemistry & Molecular Biology | 11415 | 31% | 0% | 3073 |
4 | Oncology | 9550 | 18% | 0% | 1768 |
5 | Hematology | 5866 | 8% | 0% | 814 |
6 | Medicine, Research & Experimental | 1601 | 6% | 0% | 590 |
7 | Rheumatology | 881 | 2% | 0% | 202 |
8 | Biophysics | 608 | 4% | 0% | 398 |
9 | Endocrinology & Metabolism | 541 | 4% | 0% | 415 |
10 | Neurosciences | 443 | 7% | 0% | 665 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COOPERAT CELLULAR GROWTH TORS | 59881 | 0% | 48% | 41 |
2 | MOL CELLULAR IMMUNOL | 38698 | 1% | 23% | 56 |
3 | MOL IMMUNOL INFLAMMAT BRANCH | 27919 | 0% | 22% | 42 |
4 | WALTER ELIZA HALL MED | 20784 | 1% | 7% | 98 |
5 | COLON MOL CELL BIOL | 20767 | 0% | 57% | 12 |
6 | SECT PATHOPHYSIOL | 19265 | 0% | 29% | 22 |
7 | CANC HAEMATOL | 14909 | 0% | 19% | 26 |
8 | SIGNALING GRP STAT5 | 12624 | 0% | 83% | 5 |
9 | SIGNAL NETWORK | 11891 | 0% | 30% | 13 |
10 | GRP RECH CYTOKINES RECEPTEURS | 11399 | 0% | 47% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CYTOKINE | 18424 | 2% | 4% | 165 |
2 | JOURNAL OF IMMUNOLOGY | 7696 | 4% | 1% | 382 |
3 | JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 7653 | 1% | 3% | 76 |
4 | BLOOD | 5957 | 3% | 1% | 269 |
5 | JOURNAL OF BIOLOGICAL CHEMISTRY | 5372 | 6% | 0% | 556 |
6 | CYTOKINE & GROWTH FACTOR REVIEWS | 4573 | 0% | 4% | 35 |
7 | EUROPEAN CYTOKINE NETWORK | 3926 | 0% | 4% | 36 |
8 | ONCOGENE | 3473 | 1% | 1% | 149 |
9 | MOLECULAR AND CELLULAR BIOLOGY | 2213 | 1% | 1% | 134 |
10 | IMMUNITY | 2119 | 0% | 1% | 50 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | STAT3 | 662801 | 8% | 27% | 801 | Search STAT3 | Search STAT3 |
2 | GP130 | 352419 | 2% | 52% | 225 | Search GP130 | Search GP130 |
3 | ONCOSTATIN M | 311552 | 2% | 58% | 178 | Search ONCOSTATIN+M | Search ONCOSTATIN+M |
4 | LEUKEMIA INHIBITORY FACTOR | 266481 | 2% | 41% | 216 | Search LEUKEMIA+INHIBITORY+FACTOR | Search LEUKEMIA+INHIBITORY+FACTOR |
5 | CILIARY NEUROTROPHIC FACTOR | 215322 | 2% | 44% | 162 | Search CILIARY+NEUROTROPHIC+FACTOR | Search CILIARY+NEUROTROPHIC+FACTOR |
6 | SOCS | 184932 | 1% | 52% | 118 | Search SOCS | Search SOCS |
7 | STAT | 174342 | 2% | 29% | 202 | Search STAT | Search STAT |
8 | SOCS3 | 173437 | 1% | 41% | 141 | Search SOCS3 | Search SOCS3 |
9 | SOCS1 | 164462 | 1% | 52% | 105 | Search SOCS1 | Search SOCS1 |
10 | INTERLEUKIN 11 | 159811 | 1% | 49% | 108 | Search INTERLEUKIN+11 | Search INTERLEUKIN+11 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HEINRICH, PC , BEHRMANN, I , HAAN, S , HERMANNS, HM , MULLER-NEWEN, G , SCHAPER, F , (2003) PRINCIPLES OF INTERLEUKIN (IL)-6-TYPE CYTOKINE SIGNALLING AND ITS REGULATION.BIOCHEMICAL JOURNAL. VOL. 374. ISSUE . P. 1-20 | 176 | 69% | 1511 |
2 | KIU, H , NICHOLSON, SE , (2012) BIOLOGY AND SIGNIFICANCE OF THE JAK/STAT SIGNALLING PATHWAYS.GROWTH FACTORS. VOL. 30. ISSUE 2. P. 88 -106 | 193 | 64% | 79 |
3 | AUERNHAMMER, CJ , MELMED, S , (2000) LEUKEMIA-INHIBITORY FACTOR - NEUROIMMUNE MODULATOR OF ENDOCRINE FUNCTION.ENDOCRINE REVIEWS. VOL. 21. ISSUE 3. P. 313 -345 | 265 | 63% | 154 |
4 | CROKER, BA , KIU, H , NICHOLSON, SE , (2008) SOCS REGULATION OF THE JAK/STAT SIGNALLING PATHWAY.SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. VOL. 19. ISSUE 4. P. 414-422 | 117 | 89% | 230 |
5 | HEINRICH, PC , BEHRMANN, I , MULLER-NEWEN, G , SCHAPER, F , GRAEVE, L , (1998) INTERLEUKIN-6-TYPE CYTOKINE SIGNALLING THROUGH THE GP130/JAK/STAT PATHWAY.BIOCHEMICAL JOURNAL. VOL. 334. ISSUE . P. 297 -314 | 139 | 64% | 1207 |
6 | SCHAPER, F , ROSE-JOHN, S , (2015) INTERLEUKIN-6: BIOLOGY, SIGNALING AND STRATEGIES OF BLOCKADE.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 26. ISSUE 5. P. 475 -487 | 122 | 70% | 28 |
7 | TANIGUCHI, K , KARIN, M , (2014) IL-6 AND RELATED CYTOKINES AS THE CRITICAL LYNCHPINS BETWEEN INFLAMMATION AND CANCER.SEMINARS IN IMMUNOLOGY. VOL. 26. ISSUE 1. P. 54 -74 | 167 | 43% | 99 |
8 | SANTOS, CI , COSTA-PEREIRA, AP , (2011) SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION-FROM CYTOKINE SIGNALLING TO CANCER BIOLOGY.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1816. ISSUE 1. P. 38-49 | 165 | 73% | 23 |
9 | ALEXANDER, WS , HILTON, DJ , (2004) THE ROLE OF SUPPRESSORS OF CYTOKINE SIGNALING (SOCS) PROTEINS IN REGULATION OF THE IMMUNERESPONSE.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 22. ISSUE . P. 503-529 | 118 | 84% | 454 |
10 | SIVEEN, KS , SIKKA, S , SURANA, R , DAI, XY , ZHANG, JW , KUMAR, AP , TAN, BKH , SETHI, G , BISHAYEE, A , (2014) TARGETING THE STAT3 SIGNALING PATHWAY IN CANCER: ROLE OF SYNTHETIC AND NATURAL INHIBITORS.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1845. ISSUE 2. P. 136 -154 | 135 | 48% | 105 |
Classes with closest relation at Level 2 |